# 21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug.

21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug., “Determination of reasons for voluntary withdrawal of a listed drug”, is a CFR section of [21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications](https://ontology.bommaritollc.com/id/01a0f094-b5f3-717b-b604-e7b462cd0e7c); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter D—DRUGS FOR HUMAN USE](https://ontology.bommaritollc.com/id/01a0f094-b5e4-722f-99b0-5c1856aef2a9) › [21 CFR Part 314—Applications for FDA approval to market a new drug](https://ontology.bommaritollc.com/id/01a0f094-b84d-7031-b149-cb632d656858) › [21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications](https://ontology.bommaritollc.com/id/01a0f094-b5f3-717b-b604-e7b462cd0e7c)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 314.161](https://ontology.bommaritollc.com/id/01a0f094-c4dc-7499-8606-ac9c0b319b8b)
- `eli:cites`:
  - [21 CFR 10.25 Initiation of administrative proceedings.](https://ontology.bommaritollc.com/id/01a0f094-ba67-70e4-a06b-b7174e9d98b5)
  - [21 CFR 10.30 Citizen petition.](https://ontology.bommaritollc.com/id/01a0f094-ba68-76ce-8544-809683c8c64d)
  - [21 CFR 314.153 Suspension of approval of an abbreviated new drug application.](https://ontology.bommaritollc.com/id/01a0f094-c4da-7097-8820-9280bb04f743)
  - [21 CFR 314.162 Removal of a drug product from the list.](https://ontology.bommaritollc.com/id/01a0f094-c4dc-7499-8606-ac9e60b7c6c0)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd41c8ff0b1)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e323-7516-917b-411d0257c16b)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c530-7208-80b3-f7a9c8ec5572)
  - [evidence from https://www.govinfo.gov/link/cfr/21/314?sectionnum=161&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-67cd-72ef-9be1-726c3ffbc4a6)
- `schema:isPartOf`: [21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications](https://ontology.bommaritollc.com/id/01a0f094-b5f3-717b-b604-e7b462cd0e7c)
- `schema:legislationIdentifier`: 21 CFR 314.161
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Determination of reasons for voluntary withdrawal of a listed drug
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/314?sectionnum=161&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/314?sectionnum=161&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/314?sectionnum=161&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (5; `eli:cites`):
  - [21 CFR 314.122 Submitting an abbreviated application for, or a 505(j)(2)(C) petition that relies on, a listed drug that is no longer marketed.](https://ontology.bommaritollc.com/id/01a0f094-c4d5-7607-9f58-27c9ec6ed248)
  - [21 CFR 314.127 Refusal to approve an ANDA.](https://ontology.bommaritollc.com/id/01a0f094-c4d7-7083-af55-7d1df167c579)
  - [21 CFR 314.162 Removal of a drug product from the list.](https://ontology.bommaritollc.com/id/01a0f094-c4dc-7499-8606-ac9e60b7c6c0)
  - [21 CFR 314.93 Petition to request a change from a listed drug.](https://ontology.bommaritollc.com/id/01a0f094-c4c7-7468-a53b-b8241dedaea3)
  - [21 U.S.C. 355 New drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd6-7038-b7ea-5f9e1b3b3f50)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc)
Cite as: 21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
